Clinical Trial Update: Sevoflurane and Percutaneous Coronary Intervention by Stent [Phase 4]

View source ↗

Summary

Phase 4 clinical trial about sevoflurane during percutaneous coronary intervention for myocardial infarction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Sevoflurane (Sevoflurane)

Snippet

Sponsor: Instituto Dante Pazzanese de Cardiologia | Conditions: Myocardial Infarction | Phase 4 | Status: TERMINATED